Diabetes Obesity & Metabolism HCRU

Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study

https://dx.doi.org/10.1111/dom.12916

Post author By Holden S E, Morgan C L, Qiao Q, Jenkins-Jones S, Berni E R and Currie C J
Post date 20 February 2017

Holden S E, Morgan C L, Qiao Q, Jenkins-Jones S, Berni E R, Currie C J. 20 Feb 2017

Holden S E

Morgan C L

Qiao Q

Jenkins-Jones S

Berni E R

Currie C J

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Site by Create Summit